Canopy Growth (CGC) Gross Profit (QoQ) (2019 - 2025)
Canopy Growth (CGC) Gross Profit (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Canopy Growth | 449.71 Mn | 202.70 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 176.66% |
| Sep 30, 2025 | 22.27% |
| Dec 31, 2024 | 7.76% |
| Sep 30, 2024 | -4.93% |
| Jun 30, 2024 | 46.69% |
| Mar 31, 2024 | -44.63% |
| Dec 31, 2023 | 18.65% |
| Sep 30, 2023 | 70.56% |
| Jun 30, 2023 | 121.53% |
| Mar 31, 2023 | -1,335.32% |
| Dec 31, 2022 | 922.12% |
| Sep 30, 2022 | 89.31% |
| Jun 30, 2022 | 96.39% |
| Mar 31, 2022 | -1,614.91% |
| Dec 31, 2021 | 114.16% |
| Sep 30, 2021 | -355.04% |
| Jun 30, 2021 | 186.18% |
| Mar 31, 2021 | -58.94% |
| Dec 31, 2020 | -3.64% |
| Sep 30, 2020 | 317.81% |